APG Asset Management N.V. Has $52.09 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• APG Asset Management N.V. reduced its stake in HCA Healthcare, Inc. by 8.6%, holding 162,830 shares valued at approximately $52 million after selling 15,376 shares.
• The company reported a quarterly earnings per share (EPS) of $6.84, exceeding the consensus estimate of $6.20, with revenues of $18.61 billion.
• HCA Healthcare announced a quarterly dividend of $0.72 per share, with a payout ratio of 12.11%, reflecting a commitment to returning value to shareholders.

APG Asset Management N.V. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 162,830 shares of the company's stock after selling 15,376 shares during the quarter. APG Asset Management N.V. owned about 0.07% of HCA Healthcare worth $52,088,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter worth approximately $26,000. Atwood & Palmer Inc. bought a new stake in HCA Healthcare during the first quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC boosted its position in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the period. ORG Partners LLC boosted its position in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its position in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded down $1.05 during trading hours on Tuesday, reaching $401.72. The stock had a trading volume of 1,180,566 shares, compared to its average volume of 1,273,427. The business's fifty day moving average is $375.19 and its two-hundred day moving average is $355.12. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company has a market cap of $94.00 billion, a price-to-earnings ratio of 16.89, a PEG ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the company posted $5.50 earnings per share. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HCA shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday. Royal Bank Of Canada reduced their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research report on Wednesday, July 16th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.